Article

Evaluating New-Generation Basal Insulin Therapy

https://www.pharmacytimes.org/landing/1137

https://www.pharmacytimes.org/landing/1137

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Michael Hassett, MD, MPH, Dana-Farber Cancer Institute
Emilie Aschenbrenner, PharmD, BCOP, Froedtert Health and the Medical College of Wisconsin
Clayton Irvine, PharmD, MBA, MS
Related Content
GLP-1's use, in theory should decrease preoperative risks more prevalent amongst those with obesity; however, safety considerations are still necessary. | Image Credit: AdobeStock_Anatta_Tan.jpeg
August 15th 2025

GLP-1s’ Preoperative Use Requires Safety Considerations

Sabrina McCrear
managed care cast banner
August 15th 2025

Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD

Mary Caffrey Skylar Jeremias Joseph Mikhael, MD
Chronic urticaria. | Image Credit: doucefleur - stock.adobe.com
August 15th 2025

Can Biomarkers Help Pinpoint the Right Treatment for Chronic Spontaneous Urticaria?

Cameron Santoro
AJMC podcast banner
August 15th 2025

What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD

Hayden E. Klein Skylar Jeremias Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Paper saying Medicaid eligibility | Image credit: Vitalii Vodolazskyi – stock.adobe.com
August 15th 2025

5 Key Takeaways on Medicaid Policy Changes From Savista’s Chief Strategy Officer

Hayden E. Klein Laxmi Patel
Hidradenitis suppurativa. | Image Credit: Kristina Blokhin - stock.adobe.com
August 15th 2025

GLP-1s Show Promise for Patients With Hidradenitis Suppurativa and Obesity

Laura Joszt, MA

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo